SPRC Latest Press Releases

-- August 12, 2026 --

SciSparc's Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination Globe Newswire 8:25 AM

-- August 5, 2026 --

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome Globe Newswire 8:22 AM

-- July 31, 2026 --

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics Globe Newswire 8:20 AM

-- July 29, 2026 --

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company Globe Newswire 8:32 AM

-- July 27, 2026 --

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity Globe Newswire 8:25 AM

-- July 15, 2026 --

SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome Globe Newswire 8:41 AM

-- June 4, 2026 --

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum Globe Newswire 7:32 AM

-- May 28, 2026 --

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum Globe Newswire 8:40 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software